Related Experiment Video
Updated: Apr 30, 2026

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
Published on: October 25, 2016
Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1
Jenny Sandström von Tobel1, Paola Antinori2, Marie-Gabrielle Zurich1
1Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland; Department of Physiology, University of Lausanne, CH-1005 Lausanne, Switzerland.
Abstract:
Neurotoxic effects of the environmentally abundant mycotoxin Ochratoxin A (OTA) were studied in histotypic 3D rat brain cell cultures, comprising all brain cell types. Cultures were exposed to nanomolar OTA concentrations and samples were collected 48h after a single exposure, or after 10 days of repeated administration. OTA-induced changes in gene- and protein expression, as well as alterations in cell morphology were assessed. Forty-eight-hour OTA exposure resulted in a disruption of the neuronal cytoskeleton and reduced expression of several oligodendrocyte-specific markers indicative of demyelination. Astrocyte disturbances were revealed by a decrease in two astrocytic proteins involved in regulation of inflammatory responses, metallothioneins I and II. Repeated OTA administration induced a neuroinflammatory response, as visualized by an increase of isolectin B4 labelled cells, increased expression of pro-inflammatory cytokines, and detection of macrophagic ED1/CD68 positive cells, as well as an upregulation of neurodegenerative M1 microglial phenotype markers. Partial recovery from OTA-induced deleterious effects on oligodendrocytes and astrocytes was achieved by co-treatment with sonic hedgehog (SHH). In addition, metallothionein I and II co-treatment partially restored OTA-induced effects on oligodendrocytes after 48h, and modulated microglial reactivity after 10 days. These results suggest that OTA-exposure affects Shh-signalling, which in turn may influence both oligodendrocytes and astrocytes. Furthermore, the primarily astrocytic proteins MTI/MTII may affect microglial activation. Thus the neuroinflammatory response appears to be downstream of OTA-induced effects on demyelination, axonal instabilities and astrocytes disturbances. In conclusion, repeated OTA-exposure induced a secondary neuroinflammatory response characterized by neurodegenerative M1 microglial activation and pro-inflammatory response that could exacerbate the neurodegenerative process.
Insights
The mycotoxin Ochratoxin A (OTA) causes neuroinflammation and demyelination in rat brain cells. Co-treatment with sonic hedgehog (SHH) and metallothioneins partially reversed these toxic effects, suggesting therapeutic potential.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- Ochratoxin A (OTA) is an abundant environmental mycotoxin with known neurotoxic potential.
- Understanding OTA's impact on complex brain cell interactions is crucial for assessing neurological risks.
Purpose of the Study:
- To investigate the neurotoxic effects of Ochratoxin A (OTA) on a histotypic 3D rat brain cell culture model.
- To assess the potential of sonic hedgehog (SHH) and metallothioneins (MTs) in mitigating OTA-induced neurotoxicity.
Main Methods:
- Exposure of 3D rat brain cell cultures to nanomolar concentrations of OTA.
- Analysis of gene and protein expression, cell morphology, and inflammatory markers post-exposure.
- Evaluation of co-treatment effects with SHH and MTs.
Main Results:
- OTA exposure caused neuronal cytoskeleton disruption, demyelination, and astrocyte disturbances.
- Repeated OTA administration led to significant neuroinflammation, including microglial activation and pro-inflammatory cytokine release.
- Co-treatment with SHH and MTs demonstrated partial recovery of neuronal and glial cells from OTA toxicity.
Conclusions:
- OTA exposure triggers a cascade of neurotoxic events, including demyelination and neuroinflammation.
- The Shh-signalling pathway and astrocytic metallothioneins appear to be involved in OTA's neurotoxic mechanism.
- SHH and MTs show promise in partially ameliorating OTA-induced neuroinflammation and cellular damage.
More Related Videos
10:21Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
Published on: February 16, 2018
04:02Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024